FDA Delays Zohydro Decision
The Food and Drug Administration has notified Zogenix Inc. that it is unlikely to reach a decision on the company’s powerful new painkiller, Zohydro, by…
ZGNX
Analyst: Zohydro Could Still Win FDA Approval
Zohydro, a new opioid painkiller developed by San Diego-based Zogenix (NASDAQ: ZGNX), could still be approved by the Food and Drug Administration to treat chronic…
FDA Panel Rejects New Painkiller Zohydro
A government panel of pain experts has advised the Food and Drug Administration to reject Zohydro, a new and stronger version of hydrocodone, because of…